| | 1616761-00-2 Basic information More.. |
| Product Name: | 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile | | Synonyms: | Tofacitinib Impurity 8;3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl);Tofacitinib-20;Tofacitinib Impurity YT;Tofacitinib impurity PF-05087352;Tofacitinib impurity 13/3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile;1-Piperidinepropanenitrile, 3-[(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-;3-[3-[(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-methylamino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile | | CAS: | 1616761-00-2 | | MF: | C16H19ClN6O | | MW: | 346.81 | | EINECS: | | | Mol File: | 1616761-00-2.mol |  |
- Tofacitinib Impurity G
-
- US $0.00-0.00 / mg
- 2024-05-20
- CAS:1616761-00-2
- Min. Order: 10mg
- Purity: 0.98
- Supply Ability: 10g
|
|
1616761-00-2
Recommend Suppliers |
|